Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Sponsored by Eli Lilly and Company
About this study
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Where this study is enrolling (37)
- Call 251-435-2273
Infirmary Cancer Care
Mobile, Alabama
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 520-626-3434
The University of Arizona Cancer Center - North Campus
Tucson, Arizona
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 479-872-8130
Highlands Oncology Group
Springdale, Arkansas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 650-725-3081
Stanford Cancer Center
Palo Alto, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 310-794-7333
UCLA Hematology/Oncology - Santa Monica
Los Angeles, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 37 locations
- Call 727-344-6569
Comprehensive Hematology Oncology
St. Petersburg, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 352-732-4032
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala
Ocala, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 813-745-2677
Moffitt Cancer Center
Tampa, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 706-353-2990
University Cancer & Blood Center, LLC
Athens, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Winship Cancer Institute
Atlanta, Georgia
- I'm interested
University of Chicago Medical Center
Chicago, Illinois
- Call 317-528-5173
Franciscan Health
Indianapolis, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 225-215-1185
Mary Bird Perkins Cancer Center
Baton Rouge, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 504-842-3910
Ochsner Health Ochsner Cancer Center - Baton Rouge
Baton Rouge, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 504-842-3910
Ochsner Clinic Foundation
New Orleans, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 207-303-3300
New England Cancer Specialists
Westbrook, Maine
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 781-744-8400
Lahey Hospital & Medical Center
Burlington, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 508-556-5400
Reliant Medical Group
Worcester, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 603-650-6344
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 631-261-4400 x12581
Northport VA Medical Center
Northport, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-305-3997
Columbia University Irving Medical Center
New York, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 646-608-3761
Memorial Sloan Kettering Cancer Center
New York, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 330-438-6333
Aultman Hospital
Canton, Ohio
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 614-293-3300
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T
Columbus, Ohio
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 971-262-9000
Oregon Health and Science University
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 503-249-3315
Kaiser Permanente Interstate Medical Office Central
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 803-794-7511
Lexington Medical Center
West Columbia, South Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 605-322-6900
Avera Cancer Institute- Research
Sioux Falls, South Dakota
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 865-305-8780
University of Tennessee Medical Center
Knoxville, Tennessee
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 877-632-6789
University of Texas MD Anderson Cancer Center
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713.790.3311
Houston Methodist Hospital
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 817-759-7000
The Center for Cancer and Blood Disorders
Fort Worth, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713-442-1700
Kelsey-Seybold Clinic
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 281-277-5200
USO - Texas Oncology Gulf Coast
Sugar Land, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 804-828-7999
VCU Health Adult Outpatient Pavillion
Richmond, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 434-924-4251
University of Virginia Health System
Charlottesville, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 608-261-1500
University Hospital and UW Health Clinics
Madison, Wisconsin
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Histological or cytological confirmation of NSCLC.
- ✓Part A
- ✓1. Clinical Stage II-IIIB (N0, N1, N2) treated with presurgical chemoimmunotherapy, with residual tumor present at time of surgery. Patients with a pathologic complete response are not eligible.
- ✓2. Pathologic Stage II-IIIB (N0, N1, N2) NSCLC treated with initial upfront resection.
- ✓Part B - Clinical Stage III, unresectable NSCLC, without progression on concurrent platinum-based chemoradiotherapy.
- ✓Must have disease with evidence of KRAS G12C mutation.
- ✓Must have known programmed death-ligand 1 (PD-L1) expression
- ✓Must have an ECOG performance status of 0 or 1.
- ✓Able to swallow oral medication.
- ✓Must have adequate laboratory parameters.
- ✓Contraceptive use should be consistent with local regulations for those participating in clinical studies.
- ✓Women of childbearing potential must
- ✓Have a negative pregnancy test.
- ✓Not be breastfeeding during treatment
Exclusion criteria
- ✕Have known, actionable changes in the EGFR or ALK genes.
- ✕Have another type of cancer that is progressing or required active treatment within the past 2 years before screening.
- ✕Have an active autoimmune disease that required systemic treatment in the past 2 years. Endocrine replacement therapy is allowed.
- ✕Had any immune-related side effect or allergic reaction (Grade 3 or higher) from a previous immunotherapy medicine, or any immune-related side effect greater than Grade 1 that has not resolved. This does not apply for people with hormone-related diseases who are now on stable hormone replacement therapy.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.